Sulzer Medica to license carbon technology to ATS
This article was originally published in Clinica
Executive Summary
ATS Medical is to buy a technology licence from Sulzer Medica's subsidiary Sulzer Carbomedics for $41 million to manufacture the pyrolytic carbon and metal components for the ATS mechanical heart valve. ATS will continue to buy components, at a reduced level, from Sulzer Carbomedics under an OEM agreement until the end of 2007. "We have recognised for a long period of time that it would be necessary to control our destiny and make our own carbon if we are to accomplish our goal of being number one in the heart valve business," said Manny Villafana, chairman and CEO of ATS.
You may also be interested in...
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.